Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
‘Easygoing’ mother’s shock at stress-induced broken-heart syndrome diagnosisPress Association, 2024Copyright Press Association Limited Jan 11, 2024Digital Resources/Online E-Resources |
|
2 |
Material Type: Newsletter Article
|
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese PatientsBenzinga Newswires, 20232020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
4D Molecular Discloses Updated Data From Currently Paused Fabry Disease Cardiomyopathy StudyBenzinga Newswires, 20232020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Clinical Trial: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse RemodelingUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 10, 2024Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Clinical Trial: Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic CardiomyopathyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 8, 2024Digital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy StudyBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy TrialBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Andrés Felipe Román doubts whether he will remain at Millonarios: the issue of his contract renewal is still in questionCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? -- IBDDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Mar 4, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Are you under 35 years old? This is the leading cause of sudden deathCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Bristol Myers Squibb Announces Topline Results From Phase 3 VALOR-HCM Trial; Study Met Primary Endpoint At Week 16Benzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Bristol Myers Squibb's Mavacamten Aces Late-Stage Trial In CardiomyopathyBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Cardiomyopathy, one of the most common diseases in Spain: symptoms and how to prevent sudden deathCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024News Bites - Healthcare & Equipment, 2024Copyright News Bites Pty Ltd Jan 19, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Cardiovascular Imaging Journal Issues Research Articles in Nov. 1, 2023 EditionTargeted News Service, 2023Targeted News ServiceDigital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Millonarios president rules out lawsuit against Boca Juniors for Andrés Felipe RománCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Andrés Felipe Román: step from being withdrawn by Boca's doctors to the call-up of the Colombian National TeamCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Cytokinetics Shares Gain On Positive Data From Heart Disease CandidateBenzinga Newswires, 20212020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
BridgeBio Pharma Reports Positive Phase 3 Data for Cardiomyopathy Drug TrialDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Jul 17, 2023Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Player ruled out by Boca due to heart abnormality will return to play in ColombiaCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |